Delivery Order SPE2DB20D3303-SPE2DB25FA4FT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management in military and veteran healthcare systems. The order, valued at $1,465.15 with a firm fixed price structure, was competitively awarded without set-aside restrictions and is scheduled for completion by August 21, 2025. Performance will be executed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning September 21, 2023. The order is placed against an existing DLA contract vehicle to support the agency's procurement of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Atorvastatin 20 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,093.56. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $14,000 delivery order to Amerisourcebergen Drug Corporation for 500 tablets of the cholesterol medication atorvastatin. As the prime contractor, Amerisourcebergen will supply the generic statin to the DLA under a firm fixed price contract executed from July 7-10, 2023. The parent company, Amerisourcebergen Corporation, will perform the order through its Conshohocken, Pennsylvania distribution facility. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $79,410 to Amerisourcebergen Drug Corporation to supply 500 tablets of the generic cholesterol medication atorvastatin. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by July 24, 2023 under the terms of the contract. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand dollars to Amerisourcebergen Drug Corporation for atorvastatin 20 mg tablets. Under the contract, Amerisourcebergen will deliver 500 strips of the generic cholesterol medication to a facility in Conshohocken, Pennsylvania by September 14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $28,000 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a commonly prescribed drug...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $28,000 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 22nd and 23rd, 2023. The Defense Logistics Agency manages the Department of Defense's supply chain and procurement programs, and this order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred forty-two dollars and seventy cents to Amerisourcebergen Drug Corporation for the provision of five hundred tablets of atorvastatin 20 mg. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is limited to August 15 through August 16, 2023. As a top pharmaceutical supplier to the Department of Defense, Amerisourcebergen will deliver the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The order is for 4,564,097,707 units of Atorvastatin 10 mg tablets, a generic pharmaceutical product, with a ceiling value of $3,735.53. The delivery order has an ultimate completion date of March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA4FTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Atorvastatin 20 mg, a commonly prescribed statin medication for cholesterol management. Valued at $1,236.60 with a firm fixed price structure, this delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 29, 2025. The order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which serves as a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order reflects the company's ongoing role in supporting the Defense Health Agency and broader military healthcare operations through DLA's centralized pharmaceutical supply chain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/26/25 |